PosaconazolePrimary adrenal insufficiency: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1661卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33567-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：279 / 279

相关论文

共 50 条

[21] PembrolizumabPancolitis, pneumonitis and adrenal insufficiency: 3 case reports
Reactions Weekly, 2022, 1905 (1) : 422 - 422
[22] Nivolumab/pembrolizumabCentral adrenal insufficiency: 3 case reports
Reactions Weekly, 2018, 1712 (1) : 406 - 406
[23] NivolumabDiarrhoea, fatigue and adrenal insufficiency: 3 case reports
Reactions Weekly, 2020, 1796 (1) : 186 - 186
[24] Clobetasol/dexamethasoneIatrogenic Cushing's syndrome and adrenal insufficiency: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 411 - 411
[25] Lenvatinib/vandetanibPrimary adrenal insufficiency and hypertension: 11 case reports
Reactions Weekly, 2019, 1746 (1) : 116 - 116
[26] Corticosteroids/ritonavir interactionSecondary adrenal insufficiency: 23 case reports
Reactions Weekly, 2019, 1752 (1) : 110 - 110
[27] Nivolumab/sitravatinib/tislelizumabEndocrinopathies in the form of adrenal insufficiency and addisonian crisis: 2 case reports
Reactions Weekly, 2021, 1847 (1) : 365 - 365
[28] Durvalumab/etoposideGrade 2 interstitial lung disease and Grade 3 adrenal insufficiency: 2 case reports
Reactions Weekly, 2025, 2049 (1) : 143 - 143
[29] BezafibrateRenal insufficiency: 2 case reports
Reactions Weekly, 2011, 1380 (1) : 10 - 10
[30] GemcitabineRespiratory insufficiency?: 2 case reports
Reactions Weekly, 1998, 704 (1) : 8 - 8

← 1 2 3 4 5 →